Literature DB >> 6358251

Comparison of slide agglutination test and direct immunofluorescence assay for identification of Legionella isolates.

W L Thacker, H W Wilkinson, R F Benson.   

Abstract

It is technically impractical for many clinical laboratories to use the direct immunofluorescence assay for identifying and serogrouping clinical isolates of Legionella. We compared the results obtained with the direct immunofluorescence assay with the results of a simple and less-demanding slide agglutination test for identifying 15 serogroups representing seven Legionella species. The slide agglutination test was in complete agreement with the direct immunofluorescence assay, and the serogroup to which 64 clinical isolates of Legionella belonged was correctly identified. With polyvalent, pooled antisera and absorbed, serogroup-specific antisera, the slide agglutination test is a useful alternative to the direct immunofluorescence assay in the diagnosis of Legionella infections and for studying the serological relationships of Legionella-like organisms.

Entities:  

Mesh:

Year:  1983        PMID: 6358251      PMCID: PMC272851          DOI: 10.1128/jcm.18.5.1113-1118.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  The International Reference Preparation for Opacity; notes and description.

Authors:  O MAALØE
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

2.  Detection of Legionnaires disease bacteria by direct immunofluorescent staining.

Authors:  W B Cherry; B Pittman; P P Harris; G A Hebert; B M Thomason; L Thacker; R E Weaver
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

3.  Four serogroups of Legionnaires' disease bacteria defined by direct immunofluorescence.

Authors:  R M McKinney; L Thacker; P P Harris; K R Lewallen; G A Hebert; P H Edelstein; B M Thomason
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

4.  Legionella pneumophila serogroup six: isolation from cases of legionellosis, identification by immunofluorescence staining, and immunological response to infection.

Authors:  R M McKinney; H W Wilkinson; H M Sommers; B J Fikes; K R Sasseville; M M Yungbluth; J S Wolf
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

5.  A fifth serogroup of Legionella pneumophila.

Authors:  A C England; R M McKinney; P Skaliy; G W Gorman
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

6.  Atypical Legionella-like organisms: fastidious water-associated bacteria pathogenic for man.

Authors:  L G Cordes; H W Wilkinson; G W Gorman; B J Fikes; D W Fraser
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

7.  Legionella gormanii sp. nov.

Authors:  G K Morris; A Steigerwalt; J C Feeley; E S Wong; W T Martin; C M Patton; D J Brenner
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

8.  Detection of cell-associated or soluble antigens of Legionella pneumophila serogroups 1 to 6, Legionella bozemanii, Legionella dumoffii, Legionella gormanii, and Legionella micdadei by staphylococcal coagglutination tests.

Authors:  H W Wilkinson; B J Fikes
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

9.  Classification of the Legionnaires' disease bacterium: Legionella pneumophila, genus novum, species nova, of the family Legionellaceae, familia nova.

Authors:  D J Brenner; A G Steigerwalt; J E McDade
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

10.  Legionella longbeachae species nova, another etiologic agent of human pneumonia.

Authors:  R M McKinney; R K Porschen; P H Edelstein; M L Bissett; P P Harris; S P Bondell; A G Steigerwalt; R E Weaver; M E Ein; D S Lindquist; R S Kops; D J Brenner
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

View more
  16 in total

1.  First isolation in Europe of Legionella feeleii from two cases of pneumonia.

Authors:  F Lo Presti; S Riffard; C Neyret; M Célard; F Vandenesch; J Etienne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

2.  Cellular fatty acid compositions and isoprenoid quinone contents of 23 Legionella species.

Authors:  M A Lambert; C W Moss
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  Normocellular bacterial meningitis. Case reports.

Authors:  K E Collingham; M Synnott
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

4.  Identification of Legionella pneumophila with commercially available immunofluorescence test.

Authors:  R J Fallon
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

5.  Identification of 22 Legionella species and 33 serogroups with the slide agglutination test.

Authors:  W L Thacker; B B Plikaytis; H W Wilkinson
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

6.  Isolation of Legionella anisa from a hospital hot water system.

Authors:  N Bornstein; C Vieilly; D Marmet; M Surgot; J Fleurette
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

7.  Second serogroup of Legionella feeleii strains isolated from humans.

Authors:  W L Thacker; H W Wilkinson; B B Plikaytis; A G Steigerwalt; W R Mayberry; C W Moss; D J Brenner
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

8.  Cross-reactions in Legionella antisera with Bordetella pertussis strains.

Authors:  R F Benson; W L Thacker; B B Plikaytis; H W Wilkinson
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

9.  Immunologic response of patients with legionellosis against major protein-containing antigens of Legionella pneumophila serogroup 1 as shown by immunoblot analysis.

Authors:  J S Sampson; B B Plikaytis; H W Wilkinson
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

10.  Cross-reactivity among Legionella species and serogroups.

Authors:  C Pelaz; L García Albert; C M Bourgon
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.